ARCHIVES

A Take-Home Message From ASCO 2014: NCI-Funded Clinical Research In Jeopardy,bSociety Focuses on Value of NCTN Groups

This article is from The Cancer Letter archive.

Vol. 40 No. 23 | June 6, 2014

Download PDF Visit The Full Archive

Related Articles

Fewer, Larger RT Doses Cut Recurrence Of Early Breast Cancer, UK Study Finds

June 29, 2007

ASCO Annual Meeting: PARP Inhibitors Show Promise Against Breast Cancer In Small Phase II Studies

June 5, 2009

NIH Panel Outlines Strategies To Manage Adrenal Tumors.

February 22, 2002

Major Changes In NCI Drug screening Tumor Panels Approved

June 18, 1982

Three Organizations Publish Guideline For Biomarker Testing for Targeted Therapies

April 26, 2013

Ovariectomy Without HRT Increases Death Rate

September 29, 2006